Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rua BioscienceNZSE:RUA Days Inventory is 110.09 as of Dec. 2025, which is 43% below its 10-year median of 194.47. The stock has 4 warning signs investors should review. Among 922 Drug Manufacturers companies, Rua Bioscience ranks better than 68.33% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Rua Bioscience's Average Total Inventories for the
six
months ended in Dec. 2025 was NZ$0.54 Mil. Rua Bioscience's Cost of Goods Sold for the
six
months ended in Dec. 2025 was NZ$0.90 Mil.
Hence, Rua Bioscience's Days Inventory for the
six
months ended in Dec. 2025 was 110.09.
The historical rank and industry rank for Rua Bioscience's Days Inventory or its related term are showing as below:
NZSE:RUA'
s Days Inventory Range Over the Past 10 Years
Min: 123.42 Med: 194.47 Max: 624.49
Current: 123.42
During the past 5 years, Rua Bioscience's highest Days Inventory was 624.49. The lowest was 123.42. And the median was 194.47.
NZSE:RUA's Days Inventory is ranked better than 68.33% of 922
companies
in the Drug Manufacturers industry
Industry Median: 164.72
vs NZSE:RUA: 123.42
Rua Bioscience's Days Inventory
declined
from Dec. 2024 (112.61) to Dec. 2025 (110.09).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Rua Bioscience's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.66.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Rua Bioscience's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.41.
Rua Bioscience (NZSE:RUA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Rua Bioscience's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Rua Bioscience's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Rua Bioscience Days Inventory Related Terms
Rua Bioscience Days Inventory Historical Data
* Premium members only.
The historical data trend for Rua Bioscience's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:RUA vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Rua Bioscience's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rua Bioscience Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rua Bioscience's Days Inventory distribution charts can be found below:
* The bar in red indicates where Rua Bioscience's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rua Bioscience (NZSE:RUA) has a Days Inventory of 110.09 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Rua Bioscience and its competitors. This is 43% below median its historical median of 194.47. Over the past decade, Rua Bioscience's Days Inventory has ranged from 123.42 to 624.49. According to the industry distribution chart, Rua Bioscience ranks #292 out of 922 companies in the Drug Manufacturers industry, placing it in the top 31.7%.
Is Rua Bioscience's Days Inventory too high?
Rua Bioscience's current Days Inventory of 110.09 is 43% below median its 10-year median of 194.47. Over the past 10 years, this metric has ranged from a low of 123.42 to a high of 624.49. The Drug Manufacturers industry median Days Inventory is 164.72. Rua Bioscience's value of 110.09 is 33.2% below this industry median. Based on the distribution chart, Rua Bioscience ranks #292 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Rua Bioscience's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Rua Bioscience ranks #292 out of 922 companies for Days Inventory. This puts Rua Bioscience in the upper half of its industry. The industry median Days Inventory is 164.72. Rua Bioscience's value of 110.09 is 33.2% below this benchmark. Historically, Rua Bioscience's own Days Inventory has ranged from 123.42 to 624.49 over the past decade. While the company's 10-year median is 194.47 vs. the industry median of 164.72, Rua Bioscience has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.72, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rua Bioscience's current Days Inventory of 110.09 is 33.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Rua Bioscience and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rua Bioscience's current Days Inventory is 110.09, which is 43% below median its own 10-year median of 194.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rua Bioscience stock overvalued right now?
Rua Bioscience (NZSE:RUA) has a current Days Inventory of 110.09. The current Days Inventory is 110.09, which is 43% below median its 10-year median of 194.47 and 33.2% below the Drug Manufacturers industry median of 164.72. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Rua Bioscience (NZSE:RUA), the current Days Inventory is 110.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany, and New Zealand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:RUA has been successfully added to your 
